Monday, September 16, 2013

Vol. 19, No. 18

TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 19, No. 18 September 16, 2013
(The next issue will be on October 1, 2013)
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None Submitted for this issue.
__________________________________________________________
UPCOMING MEETINGS & EVENTS
General info on upcoming meetings of interest:
http://tf7.org/meetings.htm

ISTH also maintains a list of upcoming meetings of interest:
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":

Abdel-Meguid ME (2013) Prophylactic administration of recombinant activated factor VII in coronary revascularization surgery. Saudi J Anaesth 7:301-304.
http://www.ncbi.nlm.nih.gov/pubmed/24015134

Ben-Hadj-Khalifa S, Lakhal B, Nsiri B, Mahjoub T, Almawi WY (2013) Factor VII levels, R353Q and -323P0/10 Factor VII variants, and the risk of acute coronary syndrome among Arab-African Tunisians. Mol Biol Rep 40:3793-3798.
http://www.ncbi.nlm.nih.gov/pubmed/23275237

Bensen-Kennedy D (2013) Bringing new therapy options to the hemophilia community. Thromb Res 131 Suppl 2:S15-18.
http://www.ncbi.nlm.nih.gov/pubmed/23537722

Breitenstein A, Akhmedov A, Camici GG, Luscher TF, Tanner FC (2013) p27 inhibits tissue factor expression. Biochem Biophys Res Commun.
http://www.ncbi.nlm.nih.gov/pubmed/24021283

Camkiran A, Pirat A, Zeyneloglu P, Ozkan M, Arslan G (2013) Use of recombinant activated factor VIIa for nonsurgical, refractory bleeding in neonatal cardiac surgery patients: case series. J Cardiothorac Vasc Anesth 27:e14-15.
http://www.ncbi.nlm.nih.gov/pubmed/23507020

Chan HC, Ke LY, Chu CS, Lee AS, Shen MY, Cruz MA, . . . Chen CH (2013) Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/24030386

Cheng V, Kashyap SR, Schauer PR, Kirwan JP, McCrae KR (2013) Restoration of glycemic control in patients with type 2 diabetes mellitus after bariatric surgery is associated with reduction in microparticles. Surg Obes Relat Dis 9:207-212.
http://www.ncbi.nlm.nih.gov/pubmed/22093380

Dewhirst E (2013) Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 2: is recombinant factor VIIa beneficial in the management of acute spontaneous intracerebral haemorrhage? Emerg Med J 30:340-341.
http://www.ncbi.nlm.nih.gov/pubmed/23511942

Elizalde M, Slobodskoy L, Diodato M, Chang J, Chedrawy EG (2012) Use of recombinant factor VII in cardiac surgery. Recent Pat Cardiovasc Drug Discov 7:216-220.
http://www.ncbi.nlm.nih.gov/pubmed/22812609

Fink MP (2013) Animal models of sepsis. Virulence 5.
http://www.ncbi.nlm.nih.gov/pubmed/24022070

Franchini M, Coppola A, Tagliaferri A, Lippi G (2013) FEIBA versus NovoSeven in Hemophilia Patients with Inhibitors. Semin Thromb Hemost.
http://www.ncbi.nlm.nih.gov/pubmed/24014071

Gheldof D, Hardij J, Cecchet F, Chatelain B, Dogne JM, Mullier F (2013) Thrombin generation assay and transmission electron microscopy: a useful combination to study tissue factor-bearing microvesicles. J Extracell Vesicles 2.
http://www.ncbi.nlm.nih.gov/pubmed/24009889

Jy W, Johansen ME, Bidot Jr C, Horstman L, Ahn YS (2013) Red cell-derived microparticles (RMP) as haemostatic agent. Thromb Haemost 110:751-760.
http://www.ncbi.nlm.nih.gov/pubmed/24030707

Keshava S, Kothari H, Rao LV, Pendurthi UR (2013) Influence of endothelial cell protein C receptor on breast cancer development. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/24024878

Keshava S, Sahoo S, Tucker TA, Idell S, Rao LV, Pendurthi UR (2013) Endothelial cell protein C receptor opposes mesothelioma growth driven by tissue factor. Cancer Res 73:3963-3973.
http://www.ncbi.nlm.nih.gov/pubmed/23539451

Landsem A, Nielsen EW, Fure H, Christiansen D, Ludviksen JK, Lambris JD, . . . Brekke OL (2013) C1-inhibitor efficiently inhibits Escherichia coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and coagulation activation in human whole blood. Clin Exp Immunol 173:217-229.
http://www.ncbi.nlm.nih.gov/pubmed/23607270

Liu ZL, Yang L, Liu MM, Bai O, Cui JW, Li PT, Li W (2012) [Clinical analysis of recombinant activated factor VIIa for 18 patients with severe bleeding]. Zhonghua Xue Ye Xue Za Zhi 33:409-411.
http://www.ncbi.nlm.nih.gov/pubmed/22781803

Marchetti M, Tartari CJ, Russo L, Panova-Noeva M, Leuzzi A, Rambaldi A, . . . Falanga A (2013) Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with Essential Thrombocythemia. Am J Hematol.
http://www.ncbi.nlm.nih.gov/pubmed/24009132

Mundkur L, Mukhopadhyay R, Samson S, Varma M, Kale D, Chen D, . . . Kakkar VV (2013) Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J mice. PLoS One 8:e58364.
http://www.ncbi.nlm.nih.gov/pubmed/23505495

Owens AP, 3rd, Byrnes JR, Mackman N (2013) Hyperlipidemia, tissue factor, coagulation, and simvastatin. Trends Cardiovasc Med.
http://www.ncbi.nlm.nih.gov/pubmed/24016468

Pepke W, Eisenreich A, Jaster M, Ayral Y, Bobbert P, Mayer A, . . . Rauch U (2013) Bivalirudin inhibits periprocedural platelet function and tissue factor expression of human smooth muscle cells. Cardiovasc Ther 31:115-123.
http://www.ncbi.nlm.nih.gov/pubmed/22212466

Raja O, Imane S, Saadia F, Bouchra O (2013) Leck of Congenital factor VII. Tunis Med 91:482-483.
http://www.ncbi.nlm.nih.gov/pubmed/24008890

Siegal DM, Cuker A (2013) Reversal of novel oral anticoagulants in patients with major bleeding. J Thromb Thrombolysis 35:391-398.
http://www.ncbi.nlm.nih.gov/pubmed/23389753

Smith JE (2013) The use of recombinant activated factor VII (rFVIIa) in the management of patients with major haemorrhage in military hospitals over the last 5 years. Emerg Med J 30:316-319.
http://www.ncbi.nlm.nih.gov/pubmed/22609697

Stephenson K, Neuenschwander PF, Kurdowska AK (2013) The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women. Int J Pharm Compd 17:74-85.
http://www.ncbi.nlm.nih.gov/pubmed/23627249

Tucker TA, Jeffers A, Alvarez A, Owens S, Koenig K, Quaid B, . . . Idell S (2013) Plasminogen Activator Inhibitor-1 Deficiency Augments Visceral Mesothelial Organization, Intrapleural Coagulation and Lung Restriction in Mice with Carbon Black/Bleomycin-Induced Pleural Injury. Am J Respir Cell Mol Biol.
http://www.ncbi.nlm.nih.gov/pubmed/24024554

Zhang X, Glunz PW, Jiang W, Schmitt A, Newman M, Barbera FA, . . . Scott Priestley E (2013) Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF-FVIIa inhibitors. Bioorg Med Chem Lett 23:1604-1607.
http://www.ncbi.nlm.nih.gov/pubmed/23416003

Zhao Y, Zhang D, Wang S, Tao L, Wang A, Chen W, . . . Lu Y (2013) Holothurian glycosaminoglycan inhibits metastasis and thrombosis via targeting of nuclear factor-kappaB/tissue factor/Factor Xa pathway in melanoma B16F10 cells. PLoS One 8:e56557.
http://www.ncbi.nlm.nih.gov/pubmed/23437168

__________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.

DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________